Yu-Jet Co., Ltd.
Update:2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Drug R&D: In addition to new drug development, it integrates medical devices and a clinical decision support system (CDSS), forming a comprehensive treatment approach centered on “drug × system × data.”
In-licensed product portfolio: The current product pipeline covers epilepsy, Fabry’s disease, and cytomegalovirus (CMV) infection, with multiple dosage forms including buccal solutions and injections.
Precision medicine systems: Clinical decision support systems, EEG and full-body stress sensing devices.
In-licensed product portfolio: The current product pipeline covers epilepsy, Fabry’s disease, and cytomegalovirus (CMV) infection, with multiple dosage forms including buccal solutions and injections.
Precision medicine systems: Clinical decision support systems, EEG and full-body stress sensing devices.
The content above was translated by Ai
Founded Year
2014
Unified Business No.
24756152
Status
Active
Number of Employees
0
Total Paid-in
Capital
177,163,840 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Yu-Jet is a Taiwan-based biotech company focused on developing treatments for rare diseases. It integrates drug formulation development, clinical research, and clinical decision support systems (CDSS), built upon three pillars: drug development, precision medicine, and clinical application. The company targets rare diseases and central nervous system (CNS) disorders, and accelerates the introduction of innovative therapies through strategic partnerships with global pharmaceutical companies. Its CDSS platform combines clinical data, AI algorithms, and medical knowledge bases to support physicians in diagnosis and treatment decisions, improving efficiency and patient safety.
The content above was translated by Ai